Evaluation of Selected New Drugs: 1988

Abramowicz M. (1988a). The Medical Letter, 30, 53–54.

Abramowicz M. (1988b). The Medical Letter, 30, 109–111.

Abramowicz M. (1988c). The Medical Letter, 30, 98–99.

Abramowicz M. (1988d). The Medical Letter, 30, 77–78.

Ganginella T.S. O'Dorisio T.M. (1988). Octreotide: Entering the new era of peptomimetic therapy. Drug Intelligence and Clinical Pharmacy, 22, 154–155.

Hasegawa G.R. (1988). Nicardipine and bepridil: New calcium channel antagonists for cardiovascular disease. Clinical Pharmacology, 7, 97–104.

Kastrup E.K. (Ed.) (1989). Facts and comparisons. Philadelphia: J.B. Lippincott Co.

Kistenansky P.M. & Cluston R.J. (1988). Astemizole: A long-acting, non-sedating antihistamine. Drug Intelligence and Clinical Pharmacy, 21, 947–953.

Monk J.P. & Clissold S.P. (1987). Misoprostol: A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of peptic ulcer disease. Drugs, 33, 1.

Rosenberg J.M. (1988). Octreotide: A synthetic analog of somatostatin. Drug Intelligence and Clinical Pharmacy, 22, 748–754.

Skoutakis V.A. Carter C.A. Sorkin E.M. , & Todd P.A. (1988). Review of diclofenac and evaluation of its place in therapy as a nonsteroidal antiinflammatory agent. Drug Intelligence and Clinical Pharmacy, 22, 850–859.

Sorkin E.M. & Clissold S.P. (1988). Nicardipine. Drugs, 33, 296–346.

Todd P.A. & Sorkin E.M. (1988). Diclofenac sodium: A reappraisal of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy. Drugs, 35, 244.

Van Sonnenberg E. & Hofmann A.F. (1988). Horizons in gallstone therapy—1988. American Journal of Radiology, 150, 43.

Zalupski M. & Baker L.H. (1988). Ifosfamide. Journal of the National Cancer Institute, 80, 8.